- Report
- June 2025
- 400 Pages
Global
From €4336EUR$4,949USD£3,742GBP
- Report
- October 2025
- 1400 Pages
Global
From €4376EUR$4,995USD£3,777GBP
- Report
- January 2026
Global
From €4293EUR$4,900USD£3,705GBP
- Report
- April 2025
Global
From €4293EUR$4,900USD£3,705GBP
- Report
- October 2025
Global
From €4293EUR$4,900USD£3,705GBP
- Report
- January 2026
- 196 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- January 2026
- 197 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- January 2026
- 192 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- January 2026
- 190 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- February 2026
- 224 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- January 2026
- 187 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- January 2026
- 186 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- April 2025
- 200 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- November 2025
- 200 Pages
Global
From €6965EUR$7,950USD£6,011GBP
- Report
- January 2026
- 180 Pages
Global
From €3943EUR$4,500USD£3,402GBP
- Report
- January 2026
- 182 Pages
Global
From €3943EUR$4,500USD£3,402GBP
- Report
- September 2025
- 250 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- April 2025
- 200 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- February 2025
- 200 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- January 2026
- 180 Pages
Global
From €3943EUR$4,500USD£3,402GBP

Melanoma is a type of cancer that affects the skin and is the most serious form of skin cancer. It is caused by the uncontrolled growth of pigment-producing cells, known as melanocytes. Melanoma is the fifth most common cancer in the United States, with an estimated 87,110 new cases in 2020. It is also the leading cause of death from skin disease.
The melanoma market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be driven by the increasing adoption of targeted therapies, immunotherapies, and combination therapies. Additionally, the increasing focus on personalized medicine and the development of novel drug delivery systems are expected to drive the market.
Some of the key players in the melanoma market include Bristol-Myers Squibb, Merck & Co., Novartis, Roche, Pfizer, and Eli Lilly. Show Less Read more